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1184conditions, MHO and ﬁt obese, have not yet been
adequately investigated, thereby leaving a void that
requires further exploration.
In the recent paper by Chang et al. (8), coronary
artery calcium (CAC) scores were assessed among
Korean subjects; they had a very low prevalence
of obesity and CAC compared with people in the
United States and India but had higher CAC scores,
even among those with MHO. Although the
investigators tried to assess the performance of
regular exercise, there was no detailed assessment
of physical activity or CRF. Future studies should
combine the important components of metabolic
health and CRF to determine the impact of adiposity
on cardiovascular disease. The need for a healthy
metabolic proﬁle and CRF cannot be understated
and should be promoted, irrespective of body mass
index or CAC score.*Abraham Samuel Babu, MPT
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Metabolically Healthy Body Composition
in Cardiovascular DiseaseWe thank Dr. Babu and colleagues and Dr. Scherbakov
and colleagues for their interest in our paper (1)
and for addressing important points in the
interpretation of our results. Several of the
arguments of Dr. Scherbakov and colleagues address
the issue of categorization of parameters that have an
underlying continuous distribution, such as coronary
artery calcium (CAC) scores or body mass index
(BMI). The actual cutoffs used for these parameters
are arbitrary and established for clinical convenience
but do not reﬂect changes in the underlying
biological processes. With regard to CAC, cutoffs have
been developed for risk stratiﬁcation; however, CAC
scores have a direct continuous relationship to total
coronary plaque burden in histology (2), severity of
coronary artery disease (3), and risk of coronary
artery disease, including comparisons of very low
CAC scores with a score of 0 (4,5). In our analysis,
we used a cutoff of 80 Agatston units (6,7) in
multinomial logistic regression models because of the
low prevalence of elevated CAC scores; only 13
subjects (0.1%) had a CAC score >400, and 80
Agatston units corresponded approximately to the
90th percentile of participants with any detectable
CAC. These results were consistent with alternative
analyticalmodels presented in the paper, including us-
ing CAC scores as a continuous outcome. Regardless of
the analytical methods, metabolically healthy obese
participants had a higher prevalence of subclinical
coronary atherosclerosis compared with metabolically
healthy participants with normal weight, and this
association persisted after adjustment for potential
confounders, including sex, cigarette smoking, and
alcohol consumption.
With regard to BMI, there is an extensive body of
evidence that, for the same level of BMI, Asian
subjects have higher total body fat (8) and a higher
risk of cardiometabolic disease (9) compared with
white subjects. Thus, a World Health Organization
consultation proposed Asian Paciﬁc–speciﬁc BMI
criteria (10), which have gained widespread accep-
tance. Irrespective of the cutoffs and the characteris-
tics of the study populations, the mechanisms linking
higher BMI to subclinical atherosclerosis are likely to
be similar across populations.
Both Dr. Babu and colleagues and Dr. Scherbakov
and colleagues discuss the obesity paradox and indi-
cate that BMI has a U-shaped relationship with mor-
tality. The obesity paradox is a complex phenomenon
and affects primarily studies of subjects older than
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118550 years of age or with established comorbidities
(11–15), raising concerns about selection, survival,
treatment, and confounder biases (14). The relevance
of the obesity paradox to our study population,
composed of relatively young asymptomatic Korean
men and women, is uncertain. There is, however,
an extensive body of evidence indicating that BMI
is linearly associated with the development of
metabolic abnormalities such as insulin resistance,
type 2 diabetes mellitus, and hypertension (14,16)
and with cardiovascular mortality and incidence in
the Asian population (17,18).Yoosoo Chang, MD
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